Correlation Between Bristol Myers and Lockheed Martin

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Lockheed Martin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Lockheed Martin into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Lockheed Martin, you can compare the effects of market volatilities on Bristol Myers and Lockheed Martin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Lockheed Martin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Lockheed Martin.

Diversification Opportunities for Bristol Myers and Lockheed Martin

0.26

Correlation Coefficient

Bristol Myers  Lockheed Martin

Modest diversification

The 3 months correlation between Bristol and Lockheed is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Lockheed Martin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lockheed Martin and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Lockheed Martin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lockheed Martin has no effect on the direction of Bristol Myers i.e., Bristol Myers and Lockheed Martin go up and down completely randomly.

Pair Corralation between Bristol Myers and Lockheed Martin

Assuming the 90 days trading horizon Bristol Myers Squibb is expected to generate 0.85 times more return on investment than Lockheed Martin. However, Bristol Myers Squibb is 1.18 times less risky than Lockheed Martin. It trades about 0.0 of its potential returns per unit of risk. Lockheed Martin is currently generating about -0.14 per unit of risk. If you would invest  120,866  in Bristol Myers Squibb on November 28, 2024 and sell it today you would lose (461.00) from holding Bristol Myers Squibb or give up 0.38% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Bristol Myers Squibb  vs.  Lockheed Martin

Bristol Myers Squibb

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Bristol Myers is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Lockheed Martin

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lockheed Martin has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Bristol Myers and Lockheed Martin

The main advantage of trading using opposite Bristol Myers and Lockheed Martin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Lockheed Martin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lockheed Martin will offset losses from the drop in Lockheed Martin's long position.

The idea behind Bristol Myers Squibb and Lockheed Martin pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.